Cheaper, quicker kit can help in scaling up testing: Researcher
Click here to read full article from source
India, Sept. 22 -- India's first diagnostic kit for coronavirus disease (Covid-19) based on the gene editing technology CRISPR Cas9 has been approved for commercial use by the Drug Controller General of India. The testing kit, developed by researchers from the Council for Scientific and Industrial Research-Institute of Genomics and Integrative Biology (CSIR-IGIB), was found to have high sensitivity of 96% and specificity of 98%, meaning it can accurately detect both positive and negative cases.
The cost-effective and quicker test has been named after the fictional Bengali detective Feluda who stars in series of novels by filmmaker Satyajit Ray. It is also an acronym for FNCAS9 Editor Linked Uniform Detection Assay.
The test barcodes the...
To read the full article or to get the complete feed from this publication, please Contact Us